Quintanar-Verdúguez, T. (T.)

Filtering

2019 - 201912020 - 20211

Settings

Author search.filters.isAuthorOfPublication.643a9802-c857-4545-a523-7fe9ee99d09a

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    The Medical Oncology resident mentor: situation and workload
    (Springer Science and Business Media LLC, 2019) Corral, J. (J.); Cervantes, A. (Andrés); Quintanar-Verdúguez, T. (T.); Moreno, V. (V.); Rodríguez, C.A. (C.A.); González-Flores, E. (E.); Lainez, N. (N.); Bosch-Barrera, J. (Joaquim); Elez, E. (E.)
    Purpose: The Spanish Society for Medical Oncology (SEOM, for its acronym in Spanish) and the National Commission for the Specialty of Medical Oncology seek to highlight the important workload and unrecognized dedication entailed in working as a Medical Oncology (MO) resident mentor, as well as its relevance for the quality of teaching units and the future of the specialty. Materials and methods: The current situation and opinion regarding the activity of MO resident mentors was analyzed by reviewing the standing national and autonomic community regulations and via an online survey targeting mentors, residents, and physicians who are not MO mentors. The project was supervised by a specially designated group that agreed on a proposal containing recommendations for improvement. Results: Of the MO mentors, 90% stated that they did not have enough time to perform their mentoring duties. An estimated 172 h/year on average was dedicated to mentoring, which represents 10.1% of the total time. MO mentors dedicate an average of 6.9 h/month to these duties outside their workday. Forty-five percent of the mentors feel that their role is scantly recognized, if at all. Conclusions: The study reveals the substantial dedication and growing complexity of MO resident mentoring. A series of recommendations are issued to improve the conditions in which it is carried out, including the design of systems that adapt to the professional activity in those departments that have time set aside for mentoring tasks.
  • Thumbnail Image
    Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer
    (2021) García-Gómez, J. (J.); Galve-Calvo, E. (E.); Santotoribio, J.D. (J. D.); Quintanar-Verdúguez, T. (T.); Ortiz-Muñoz, B. (B.); Gonzalez-Hernandez, A. (Alvaro); Trapé-Pujol, J. (J.); Augé-Fradera, J.M. (J. M.); Ayala-de-la-Peña, F. (F.); Cruz, S. (S.) de la
    The measurement of circulating tumour markers (TMs) for the diagnosis or monitoring of breast cancer has sometimes been considered of limited utility. In addition to the overinterpretation of irrelevant changes in marker levels, the characteristics of the patient, the disease or other pathologies that can modify them are often not considered in their evaluation. On the other hand, there are recent data on the relationship of TMs with molecular subtypes and on their prognostic value, the knowledge of which may improve their clinical utility. This consensus article arises from a collaboration between the Spanish Society of Laboratory Medicine (SEQC(ML)) and the Spanish Society of Medical Oncology (SEOM). It aims to improve the use and interpretation of circulating TMs in breast cancer. The text summarizes the current knowledge and available evidence on the subject and proposes a series of recommendations mainly focussed on the indication, the frequency of testing and the factors that should be considered for correctly interpreting changes in the levels of TMs.